Search

Your search keyword '"Xu, Song-Tao"' showing total 3 results
Start Over Author "Xu, Song-Tao" Journal journal of clinical oncology
3 results on '"Xu, Song-Tao"'

1. Gefitinib Versus Vinorelbine Plus Cisplatin as Adjuvant Treatment for Stage II-IIIA (N1-N2) EGFR-Mutant NSCLC: Final Overall Survival Analysis of CTONG1104 Phase III Trial

Author

Zhong, Wen-Zhao, primary, Wang, Qun, additional, Mao, Wei-Min, additional, Xu, Song-Tao, additional, Wu, Lin, additional, Wei, Yu-Cheng, additional, Liu, Yong-Yu, additional, Chen, Chun, additional, Cheng, Ying, additional, Yin, Rong, additional, Yang, Fan, additional, Ren, Sheng-Xiang, additional, Li, Xiao-Fei, additional, Li, Jian, additional, Huang, Cheng, additional, Liu, Zhi-Dong, additional, Xu, Shun, additional, Chen, Ke-Neng, additional, Xu, Shi-Dong, additional, Liu, Lun-Xu, additional, Yu, Ping, additional, Wang, Bu-Hai, additional, Ma, Hai-Tao, additional, Yang, Jin-Ji, additional, Yan, Hong-Hong, additional, Yang, Xue-Ning, additional, Liu, Si-Yang, additional, Zhou, Qing, additional, and Wu, Yi-Long, additional

Published
2021
Full Text
View/download PDF

2. CTONG1104: Adjuvant gefitinib versus chemotherapy for resected N1-N2 NSCLC with EGFR mutation—Final overall survival analysis of the randomized phase III trial 1 analysis of the randomized phase III trial.

Author

Wu, Yi-Long, primary, Zhong, Wenzhao, additional, Wang, Qun, additional, Mao, Weimin, additional, Xu, Song-Tao, additional, Wu, Lin, additional, Chen, Chun, additional, Cheng, Ying, additional, Xu, Lin, additional, Wang, Jun, additional, Li, Xiao-Fei, additional, Li, Jian, additional, Huang, Cheng, additional, Liu, Zhidong, additional, Xu, Shun, additional, Yang, Jin-Ji, additional, Yan, Hong-Hong, additional, Yang, Xue-Ning, additional, Liu, Si-yang, additional, and Zhou, Qing, additional

Published
2020
Full Text
View/download PDF

3. Gefitinib (G) versus vinorelbine+cisplatin (VP) as adjuvant treatment in stage II-IIIA (N1-N2) non-small-cell lung cancer (NSCLC) with EGFR-activating mutation (ADJUVANT): A randomized, Phase III trial (CTONG 1104).

Author

Wu, Yi-Long, primary, Zhong, Wenzhao, additional, Wang, Qun, additional, Xu, Song-Tao, additional, Mao, Wei-Min, additional, Wu, Lin, additional, Shen, Yi, additional, Liu, Yong-Yu, additional, Chen, Chun, additional, Cheng, Ying, additional, Xu, Lin, additional, Wang, Jun, additional, Fei, Ke, additional, Li, Xiao-Fei, additional, Li, Jian, additional, Huang, Cheng, additional, Liu, Zhi-Dong, additional, Chen, Ke-Neng, additional, Yan, Hong-Hong, additional, and Yang, Xue-Ning, additional

Published
2017
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results